Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug

por Buiter, Hans J C, Derijks, Luc, Mulder, Chris J J
Publicado 2019

High systemic gentamicin levels and ototoxicity after implantation of gentamicin beads in a 70-year-old man—a case report

por de Klaver, Paul A G, de Koning, Jan, Janssen, Rob P A, Derijks, Luc J J
Publicado 2009

Paracetamol serum concentrations in preterm infants treated with paracetamol intravenously: a case series

por van Ganzewinkel, Christ-jan JLM, Mohns, Thilo, van Lingen, Richard A, Derijks, Luc JJ, Andriessen, Peter
Publicado 2012

The Effect of Individualized Versus Standardized Parenteral Nutrition on Body Weight in Very Preterm Infants

por Evering, Vincent H. M., Andriessen, Peter, Duijsters, Carola E. P. M., Brogtrop, Jeroen, Derijks, Luc J. J.
Publicado 2017

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

por Becker, Heike E. F., Demers, Karlijn, Derijks, Luc J. J., Jonkers, Daisy M. A. E., Penders, John
Publicado 2023

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine

por Bayoumy, Ahmed B., Mulder, Chris J. J., Loganayagam, Aathavan, Sanderson, Jeremy D., Anderson, Simon, Boekema, Paul J., Derijks, Luc J. J., Ansari, Azhar R.
Publicado 2021

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

por Deben, Debbie S., Derijks, Luc J. J., van den Bosch, Bianca J. C., Creemers, Rob H., van Nunen, Annick, van Bodegraven, Adriaan A., Wong, Dennis R.
Publicado 2023

Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay

por van Aalen, Eva A., de Vries, Ivar R., Hanckmann, Eva T. L., Stevens, Jeannot R. F., Romagnoli, Thomas R., Derijks, Luc J. J., Broeren, Maarten A. C., Merkx, Maarten
Publicado 2023

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study

por Sivridaş, Merve, Creemers, Rob H., Wong, Dennis R., Boekema, Paul J., Römkens, Tessa E. H., Gilissen, Lennard P. L., van Bodegraven, Adriaan A., Loeff, Floris C., Rispens, Theo, Derijks, Luc J. J.
Publicado 2023

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

por Sluiter, Reinier L, van Marrewijk, Corine, de Jong, Dirk, Scheffer, Hans, Guchelaar, Henk-Jan, Derijks, Luc, Wong, Dennis R, Hooymans, Piet, Vermeulen, Sita H, Verbeek, André L M, Franke, Barbara, van der Wilt, Gert Jan, Kievit, Wietske, Coenen, Marieke J H
Publicado 2019

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

por Broekman, Mark M. T. J., Coenen, Marieke J. H., van Marrewijk, Corine J., Wanten, Geert J. A., Wong, Dennis R., Verbeek, Andre L. M., Klungel, Olaf H., Hooymans, Piet M., Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J. J., de Jong, Dirk J.
Publicado 2017

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

por Broekman, Mark M.T.J., Coenen, Marieke J.H., Wanten, Geert J., van Marrewijk, Corine J., Kievit, Wietske, Klungel, Olaf H., Verbeek, André L.M., Wong, Dennis R., Hooymans, Piet M., Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J.J., Bouvy, Marcel L., de Jong, Dirk J.
Publicado 2018